chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received moderna vaccine on 03/26/21 and 04/23/21. COVID positive on 1/3/22. PResented to ER on 1/3/22. presented with the shortness of breath, cough, chest tightness.  Patient was having the symptoms for 2 weeks.  Patient has a contact in the form of for her boyfriend who is positive COVID.In the ED patient received azithromycin and ceftriaxone, DuoNeb.  Patient was COVID positive.  CT chest showed possible  compression of mediastinum due to pleural effusion. Was treated with azithromycin, ceftriaxone, dexamethasone, and remdesivir. Found to have MSSA bacteremia and placed on oxacillin. Discharged on 1/18/22.
Pt states immediately after receiving the vaccine she felt sharp pain.  Today 6 days later it is still extremely red, swollen and tender.  Very painful to move arm.
I started to feel a tight/tingling feeling on the left side of my chest around July 11th. It was not constant, but I noticed it at times when I was moving and even sitting. I also felt a sharp pain down my left arm that lasted for a second. I went to the ER on July 22nd, and received an EKG and chest X-Ray. Both tests came back normal. I then followed up with my doctor on August 2nd. She stated that it was most likely inflammation after the vaccine. She instructed me to take Aleve for the pain and that the feeling was my body adjusting to the vaccine.
Child vaccinated today at Clinic about 10:30 AM after MD exam. Child was playing outside at school. Teacher noted hives on face and hands of child. Parent was notified. Mother took child directly to the Health Department for evaluation at 1:30 PM by the Public Health Nurse. Hives noted on childs face, body and limbs in a generalized fashion. No c/o itch or redness noted. Child had no respiratory distress. Dr. notified by telephone. Emergency medication protocol followed. Benadryl 30mg IM given in Rt deltoid muscle. Hives resolved within next 20 minutes time. Child observed during this time to be playing and acting normal. Mother of child advised to monitor child today at all times. If hives return and/ or any signs of respiratory distress are noted, that she must call for an ambulance to take the child to the nearest emergency room. Mother reported that the child had a new skin lotion applied to her today that the mother never used on her before. No new foods eaten lately or new laundry detergent used this week.  Parent advised to wash off any skin lotion on this child with a mild soap when she arrives home. Child discharged from clinic with faint amout of hives noted on face of child only. No distress noted.
On September 25th my leg started hurting really bad. I called Monday to make an appointment because I thought I might have done something to my muscle. I went Tuesday 09/28/2021 and I take blood thinner so my Doctor said he did not think I would have a blood clot, but they did an Ultrasound and I did have a blood clot in my leg. They put me on Eliquis and said I would need to be treated for three months.
Varicella Vaccine administered, within 2 minutes, redness and welp developed at injection site.  Errythema measured about 30mm. Some itching at site but no other symptoms.
Mild chest pain for about three days.  I noticed some irritation in my lungs that went about 5 days. I could tell there was a little bit of fluid in my lungs.  I suspect I probably had COVID-19 at least once possibly twice.  I wouldn't be surprised if I had been exposed to it previously.
Patient was given adolescent dose of HEP B in error, per RN, patient was given second dose of adolescent HEP B the same day to equal adult dose.
blood pressure which showed 90/50, pulse 50. His normal blood pressure oscillates in the range of 140-145/80-90 with a pulse of 80-90; pulse 50; dizzy; very weak; This is a spontaneous report from a contactable consumer. A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date in Apr2021 at 17:00 (at the age of 66-year-old), as dose 1, single for COVID-19 immunization. The patient's medical history included ulcerative colitis, few years in remission from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. It was unknown that if patient had received any other vaccines within 4 weeks. Since the vaccination, patient was not tested for COVID-19. It was reported that, the reporter's brother was in country. On an unspecified date in Apr2021, the next day morning after the administration of first dose of vaccine, while at work the patient felt dizzy and very weak. The patient sat in the car for about 3 hours after which he went back home. The patient checked his blood pressure which showed 90/50, pulse 50. His normal blood pressure oscillated in the range of 140-145/80-90 with a pulse of 80-90. The patient had lunch after which went to bed and slept for about 4 hours. After the patient got up, he felt fine, and his blood pressure went back up to his levels. The patient received his 2nd vaccine on 01Jun2021 and had no reaction whatsoever. Patient had not received treatment for adverse events. The patient underwent lab tests and procedures which included blood pressure measurement: 90/50 and later showed normal level; heart rate: normal, all performed on unspecified dates. The clinical outcome of all the events was resolved on an unspecified dates.  Information on the lot/batch number has been requested.  Follow-up (02Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Was seen at ER at 10:00 pm last night. Was kicking legs, twitching neck, blinking eyes, and seemed uncomfortable.
Information has been received from a doctor of pharmacy concerning a patient who on an unknown date, was vaccinated with a dose of PNEUMOVAX 23 (Lot # not reported). It was reported that the patient developed a swollen tongue a few hours after receiving the vaccine. It was unspecified if the patient sought medical attention. Additional information has been requested.
Information has been received on 5/30/01 concerning a 4 month old male received his second dose of DTAP, HIB and IPV. One week, post vax, he developed thrombocytopenia. A dx of thrombocytopenic purpura was made. Platelet count was 11,000 cells/mm3. He recovered. This event was considered "Medically Important".
pt says her left arm was swollen and had fever in it for almost 2 weeks.  The swelling has gone down now.  She had fatigue that lasted almost 2 weeks.  She developed diarrhea a couple of days after getting the vax and still has this today 4/7/2021.   She says every time she eats she gets diarrhea.  She has taken Pepto Bismol but it has not helped.  Pt will contact her PCP regarding her symptoms.
After receiving 2 doses of pfizer covid-19 vaccine. patient was directed by MD to get Janseen vaccine as well, due to not having immunity.
Information has been received from a licensed practical nurse concerning a 5 year old with no allergies who on 09/14/1999 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 12/03/01, the pt experienced chicken pox. It was reported that the lot number is not available. Unspecified medical attention was sought. Additional information has been requested.
no fever;rash started on neck face spread out all over body on 2NOV;3NOV rash cont;
Body aches started 10 hours after 2nd COVID vaccine dose, but it was unclear if this was muscle soreness related to exercise. Slept poorly and awoke around 6 AM with distinct flu-like body aches and pounding headache, as well as sweatiness and feeling hot.  Took temperature at 9 AM and found no fever, but by this time the sweats had stopped. Took two ibuprofen 200 mg each at 7:15 am and symptoms reduced.  Felt weak all day and headache persisted, took ibuprofen twice more.  The following morning, about 45 hours after vaccine, awoke again with mild headache and nausea. Didn't vomit but nausea and weakness persist and haven't alleviated yet, I am submitting this at 11:30 AM, 50 hours after vaccine.
Patient received vaccination and immediately started to bleed - not a large amount but some.  After about two minutes, I noticed what appeared to be blood pooling under the skin and the area began to become raised.  The patient did not complain of any swelling or itching.  I then applied a cold compress.  After about five minutes, the swelling had diminished so I had the patient continue with the cold compress for 15 minutes and follow up with Tylenol or Ibuprofen if swelling continued.
2nd day, upon rising. Symptoms, extreme dizziness, shaking, exhaustion, itching.  Difficulty to sit up or navigate. Stayed in bed the whole day.   Next day, no symptoms at start but symptoms returned in the afternoon, slept for 3 hours then seemed better.
Patient complains of extreme muscle pain originating from shoulder. States that it still hurts after one month, especially when he lifts his arm above his head. States that it feels painful in what might be considered the synovial fluid.
This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced debilitating pain comparable to labor pain. On APR-2021, the subject experienced arms, feet and legs going numb. On APR-2021, the subject experienced can not see straight. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arms, feet and legs going numb, debilitating pain comparable to labor pain and can not see straight was not reported. This report was non-serious. This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the subject experienced arms, feet and legs going numb. On 11-APR-2021, the subject experienced debilitating pain comparable to labor pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arms, feet and legs going numb and debilitating pain comparable to labor pain was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is considered non serious.
This case was reported by a healthcare professional and described the occurrence of itchy legs in a 29-year-old female subject who was vaccinated with FluLaval for prophylaxis. The subject had no pre-existing medical conditions. There were no concurrent medications. The subject had received influenza virus vaccine previous years with no subsequent events. On 25 October 2006 at 7:00 am, the subject received unspecified dose of FluLaval in the left thigh. On 25 October 2006 at 7:00 pm, 12 hours after vaccination with FluLaval, the subject experienced itchy legs. The subject was seen at a physician's office. The subject was treated with mineral oil (Baby oil). At the time of initial reporting, 30 October 2006, the event was ongoing. The healthcare professional considered the event was unrelated to vaccination with FluLaval.
Pt recvd MMR vax; 7 to 10 days post vax pt devel fever of 101-103, rash & malaise; pt subsequently recovered;
Within 5 minutes of injection, a few red papules developed on both arms. They were not pruritic. Following diphenhydramine 50 mg IM, no further lesions occurred. The patient was sitting comfortably.
Mom called to report adverse side effects after receiving vaccinations on 11/3/16. Received flu, Men B, and MENACTRA at appointment. About 7pm, mom states he spike a fever of 102.5 for 30 min to 1 hour with low grade fever for rest of night; gave 1 dose of TYLENOL; chills; crying; pain in left arm for about a week. Fever and chills resolved overnight.
Ten days after vaccination, I developed throbbing leg pain in both legs when sitting for more than 20 minutes. Both of my hands became cold to touch and I experienced difficulty speaking. This continued to get worse and I went to see the doctor on 4-30-2021. The doctor did not prescribe any treatment and wanted me to get an additional booster shot. My symptoms lessened over the next 3 months and were better by August of 2021 but my hands remained cold. My right hand continues to be very sensitive to temperature. No more problems with speech.
Completely stopped talking; stopped playing w/ kids; became an extremely picky eater; hates to be dirty; shuts down in groups of ppl; easily frustrated or over excited. He was diagnosed at the facility. Gets O.T. and speech therapy. Attends family therapy.
The pt had quarter-sized raised area of erythema at injection site about 1 hours, post vax, according to pt. She had a headache and occipital visual loss and congestion. MRI on 11/24/99 is consistent with ADEM. Treated with steroids. This is an addendum to the original form that I sent in on this pt on 5/16/01. It has been brought to my attention that the vaccine lot number (10163AA) written by me, may have been a misinterpretation of the actual number. The injection was given at another healthcare facility and I have been unable to talk to the nurse who actually gave the injection, to determine which of these numbers is correct. Discharge summary states brain lesion.
experienced running fever; tired; chills; This is a spontaneous report from a Pfizer sponsored program Pfizer First Connect from a contactable consumer (patient). A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 20Jan2021 as a single dose for COVID-19 immunisation, lot number: unknown. Medical history and concomitant medications were not provided. On unknown date in Jan2021 patient experienced running fever, tired and chills and wanted to know if she could take paracetamol (TYLENOL). Outcome of the events was unknown.  Information on lot number/batch number was requested.
Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.; No adverse event; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     Patient did not report any medical history/conditions, allergy, concomitant diseases and risk factor (including any previous COVID-19 diagnosis).     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.).    Patient did not received any other vaccines in the 4 weeks prior to Covid-19.  No concomitant medications were provided.  The vaccines were administered between 13-Mar-2023 to 05-Jun-2023. Patients received the vaccine either as the 3rd, 4th or 5th dose. Health care professional was looking for the availability of the vaccine.  No treatment medication was provided.  This case contains information for the 12th of 20 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-727707 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-727707:(Master Case of Patient 1 )
sore arm; lack of energy; Headaches on occasion.; This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: El1283), via an unspecified route of administration in the left arm on 18Jan2021 14:00 at a single dose for covid-19 immunization. The patient has no medical history and concomitant medications. On 19Jan2021 06:00, the patient reported sore arm, noticeable lack of energy and headaches on occasion. The patient does not have covid prior vaccination and had not tested positive post vaccination. The patient did not receive treatment for the events. The outcome of the events was not recovered.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. on 25-JUN-2012 the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number not reported) and on 18-JUN-2014 the patient was vaccinated with another dose of ZOSTAVAX (dose, route, lot number not reported). No adverse symptoms reported. Additional information has been requested.
The best way to sum up the symptoms was that he was "zombified".  Before his one-year shots he was a happy, interactive, curious child.  Everything a parent hopes for but then dreads once it happens.  For a month after his one-year immunizations he was in a constant state of apparent malaise.  He didn't play as much or as enthusiastically, he interacted less, he stopped investigating his surroundings almost entirely.  There were no physical symptoms such as fever, rash, weird smells, noticeable change in eating habits, nothing.  The only distinct and sudden change was behavioral.  After about a month he returned to his normal self.  We are recently discovering that there may be a genetic tendency towards kidney problems in his father's side of the family.  It is possible that too many shots at once overloaded his baby kidneys.  I cannot explain why this didn't seem to happen during the previous sets of immunizations when he was younger, I can only speculate that if the symptoms were present perhaps I missed them because he was too young to demonstrate curiosity and interactivity as easily.  He had to redo his one-year series shots about six months later due to the discovery that the immunizations may have been improperly stored.  I insisted they each be done separately with a spacing of a week in between.  He seemed to show a similar but shorter-lived reaction to the Hep B during the repeat injections, Hep B was the last to be administered.
Fatigue: 5/5 4pm-5/7;  Nausea: 5/5 6pm-5/6 am  Fever: 5/5 8pm-5/6 am  Chills: 5/5 8pm-5/6 am Muscle aches: 5/5 8pm-5/7 am Skin sensitivity: 5/5 8pm-5/7 am Sweating: 5/5 8pm-5/7 am injection arm sore: 5/5-present still
pt recv vax 11AM;2PM had screaming high pitch cry which lasted more than 3hr;wouldn't eat, or sleep;
6 month check seizure activity at 5:00pm 2/22/06, mom states pt had jerky movement of body and rolling of eyes. When paramedics arrived, pt's seizure activity stopped.
Mother of patient reported patient awoke with red, swollen itchy vaccine site and it was hot to the touch. Doctor notes: Patient had DTAP and Hep B (#2) in right arm. No pain to palpation. Child without fever or distress.
About 16 days following first COVID vaccine, the lymph nodes in my left armpit (same arm as shot) began to feel tender and painful. This painand tenderness then also spread into my breast tissue in my left breast and is similar to mastitis. This has persisted for 17 days with no improvement at all. I would describe it as a cross between mastitis and plurisy, as it is painful to drive, lift my arm, or really use the left arm much but also painful internally when I laugh or cough. I can recall no event where I would have pulled a muscle or bumping that side of my body and there has been no improvement over the two week"s time that it began and got worse over three days time and then has remained at same pain level.
Pt called approximately 30 minutes post vaccine, complaining of dizziness, nausea, labored breathing, burning at injection site. It was recommended she seek medical care - ER or urgent care.
1)101.9 fever the day after the Vaccine 5-2-2021 @ 6:18pm; treated with Tylenol throughout the night. Fever gone by midday 5?3-2021 2) Constant headache a few hours after the vaccine to present.  3) Fatigue a few hours after the vaccine until May 3, 2021.
FULL body rash with blistering sores.  They opened, scabbed, bled or leaked.  Was in the hospital for 4 days with no results.  He got a skin biopsy.  Result was Lupus - an autoimmune reaction.  Put on steriods and had 2 cortisone injections.
Site of injection was tender for first two days then became very sensitive/painful to touch on Wed/Thurs. Site began swelling and skin was blotch redy. Took Advil. Saw primary Dr. on Friday 11/8/02. Dr said probably cellulitis infection. Patient go IM Rocephin Fri/Sat/Sun patient well. Follow up with Dr. Monday 11/11/02.
Initial report received from a health care professional on 06 Jan 2010: This patient received one dose of the Novartis H1N1 vaccine (batch no. 102132P1) intramuscular, on 05 Jan 2010. The outcome of the event was not reported. Following an internal review on 29 Jan 2010 of the data received on 06 Jan 2010 the following correction was made: The suspect drug was recoded to S-OIV FLUVIRIN.